A case of insulinoma following total gastrectomy--effects of an alpha-glucosidase inhibitor on suppressing GIP and GLP-1 elevations

Diabetes Research and Clinical Practice
Takehiro SatoY Yamada

Abstract

A 61-year-old woman with fasting hypoglycemia following total gastrectomy was diagnosed as insulinoma. GIP and GLP-1 levels after a mixed meal were extremely increased. Administration of miglitol, an alpha-glucosidase inhibitor, suppressed the GIP and GLP-1 elevations.

References

Apr 17, 1971·British Medical Journal·R C TurnerJ D Nabarro
May 1, 1982·The Journal of Clinical Endocrinology and Metabolism·J TakemuraH Imura
Jul 21, 2004·Digestive Diseases and Sciences·Chikashi ShibataHiroo Naito
Jul 22, 2005·The New England Journal of Medicine·Geoffrey J ServiceRicardo V Lloyd
Nov 18, 2005·The New England Journal of Medicine·Thomas CarpenterAlain D Baron

❮ Previous
Next ❯

Citations

Feb 6, 2016·Obesity Surgery·Christopher M MullaMary-Elizabeth Patti
Feb 4, 2016·Clinical Endocrinology·Prapimporn Chattranukulchai ShantavasinkulLeonor Corsino
Aug 4, 2021·The Journal of Clinical Endocrinology and Metabolism·Kayo Ikeda KurakawaTakashi Kadowaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.